HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair
HIF-1alpha and VEGF in Acetaminophen Toxicity and Repair
批准号:
8094396
负责人:
Laura P James
金额:
$24.71万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-24 至 2014-05-31
关键词:
AcetaminophenAcetylcysteineAcute Liver FailureAngiogenic FactorAntidotesBindingBiological MarkersBiological ModelsCessation of lifeCyclosporineDataDevelopmentDisease modelDoseEventFoundationsFutureGene SilencingGlutathioneHIF1A geneHepaticHepatocyteHepatotoxicityHomeostasisHumanHypoxiaHypoxia Inducible FactorIncidenceKnowledgeLeadLiverMediatingMediator of activation proteinMitochondriaModelingMolecularMusNatural regenerationNecrosisNuclearOrganOrganogenesisOxidative StressOxygenPatientsPermeabilityPhasePimonidazolePlayPoisoningProcessProductionPublic HealthRecoveryReportingResearch PersonnelRoleSecondary toStagingTechnologyTestingTimeToxic effectUnited StatesUp-RegulationVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth FactorsVascular SystemWorkadductdesigneffective therapyhypoxia inducible factor 1in vivoinhibitor/antagonistliver cell proliferationliver transplantationmortalityneutralizing antibodynovelprogramsreceptorrepairedresponsetranscription factortreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Acetaminophen (APAP) is the major cause of acute liver failure (ALF) in the U.S. The antidote, N- acetylcysteine (NAC), increases hepatic GSH, decreases covalent binding and is highly effective in the early stages of toxicity. However, after the onset of toxicity, NAC has limited efficacy and there is a high incidence of liver transplant or death in these patients. This proposal will investigate mechanisms of repair of APAP-induced toxicity because novel therapies are possible with augmentation of innate repair mechanisms in ALF secondary to APAP. Our preliminary studies reveal mechanisms of hepatocyte regeneration that are critical to recovery in the late stages of APAP mediated ALF. Oxidative stress, hypoxia inducible factor 1 alpha (HIF-1?) and vascular endothelial growth factor (VEGF) appear to play central roles in the liver's response to APAP toxicity. We show that HIF-1? and VEGF are dramatically increased in the livers of APAP intoxicated mice. Also, treatment with a VEGF inhibitor markedly delays hepatocyte regeneration. It is well established, in other model systems, that HIF-1? can regulate the levels of VEGF, however this has not been previously investigated in the liver. VEGF is an angiogenic factor important in organ repair. Although hypoxia is a well described mechanism of HIF-1? induction in many models, our recent data indicate that oxidative stress induces HIF-1? and is central to APAP mediated ALF. We have shown that HIF-1? is induced in freshly isolated mouse hepatocytes treated with APAP under normoxic conditions and blocked by inhibitors of oxidative stress. Using freshly isolated hepatocytes, we recently reported that APAP induced oxidative stress and mitochondrial permeability transition leading to cellular necrosis. We will test the three following hypotheses: 1) Oxidative stress leads to HIF-1? induction in APAP-mediated hepatotoxicity in mice. 2) Nuclear factor HIF-1? is critical for upregulation of VEGF synthesis in APAP toxicity in mice. 3) The interactions of VEGF and its receptors are critical to hepatocyte regeneration following APAP toxicity in mice. Lay description: This project will examine mechanisms of repair in the liver following acetaminophen toxicity in mice treated with acetaminophen. A better understanding of the recovery processes of the liver will lead to the development of new treatments for acute liver failure.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.taap.2011.02.005
发表时间:
2011-05-01
期刊:
Toxicology and applied pharmacology
影响因子:
3.8
作者:
[Chaudhuri S, McCullough SS, Hennings L, Letzig L, Simpson PM, Hinson JA, James LP]
通讯作者:
James LP
DOI:
10.1016/j.taap.2015.02.013
发表时间:
2015-04-15
期刊:
Toxicology and applied pharmacology
影响因子:
3.8
作者:
[Yang X, Salminen WF, Shi Q, Greenhaw J, Gill PS, Bhattacharyya S, Beger RD, Mendrick DL, Mattes WB, James LP]
通讯作者:
James LP
DOI:
10.1007/978-3-642-00663-0_12
发表时间:
2010
期刊:
Handbook of experimental pharmacology
影响因子:
--
作者:
[Hinson, Jack A, Roberts, Dean W, James, Laura P]
通讯作者:
James, Laura P
Echinomycin decreases induction of vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity in mice.
Echinomycin 可降低小鼠对乙酰氨基酚毒性中血管内皮生长因子的诱导和肝细胞再生。
DOI:
10.1111/j.1742-7843.2011.00812.x
发表时间:
2012
期刊:
Basic & clinical pharmacology & toxicology
影响因子:
3.1
作者:
[Milesi-Hallé,Alessandra, McCullough,Sandra, Hinson,JackA, Kurten,RichardC, Lamps,LauraW, Brown,Aliza, James,LauraP]
通讯作者:
James,LauraP
DOI:
10.3390/metabo3030606
发表时间:
2013-08-02
期刊:
Metabolites
影响因子:
4.1
作者:
[Bhattacharyya S, Pence L, Beger R, Chaudhuri S, McCullough S, Yan K, Simpson P, Hennings L, Hinson J, James L]
通讯作者:
James L
共 9 条
CTSA Admin Supp2 Maternal Mortality - UL1 - Revision
-
批准号:10200507
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2020
-
负责人:Laura P James
-
依托单位:
CTSA Admin Supp QAQC - UL1 - Revision
-
批准号:10158964
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2019
-
负责人:Laura P James
-
依托单位:
Expanding Translational Research in Arkansas
-
批准号:9893085
-
项目类别:
-
资助金额:$411.31万
-
财政年份:2019
-
负责人:Laura P James
-
依托单位:
Expanding Translational Research in Arkansas
-
批准号:10672218
-
项目类别:
-
资助金额:$426.9万
-
财政年份:2019
-
负责人:Laura P James
-
依托单位:
Expanding Translational Research in Arkansas
-
批准号:10188670
-
项目类别:
-
资助金额:$437.9万
-
财政年份:2019
-
负责人:Laura P James
-
依托单位:
Expanding Translational Research in Arkansas
-
批准号:10443806
-
项目类别:
-
资助金额:$426.9万
-
财政年份:2019
-
负责人:Laura P James
-
依托单位:
Arkansas ECHO ISPCTN Site (AREIS)
-
批准号:10063720
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2016
-
负责人:Laura P James
-
依托单位:
Arkansas Center for Advancing Pediatric Therapeutics (ArCAPT)
-
批准号:9262528
-
项目类别:
-
资助金额:$6.91万
-
财政年份:2016
-
负责人:Laura P James
-
依托单位:
Dipstick Assay for Detection of Acetaminophen Protein Adducts
-
批准号:8013387
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2010
-
负责人:Laura P James
-
依托单位:
Biomarkers of adverse responses to acetaminophen in children and adolescents
-
批准号:8252206
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2009
-
负责人:Laura P James
-
依托单位:
Identification of new mechanistic biomarkers of adverse responses to acetaminophe
-
批准号:8063985
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2009
-
负责人:Laura P James
-
依托单位:
Identification of new mechanistic biomarkers of adverse responses to acetaminophe
-
批准号:8450902
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2009
-
负责人:Laura P James
-
依托单位:
Identification of new mechanistic biomarkers of adverse responses to acetaminophe
-
批准号:7846097
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2009
-
负责人:Laura P James
-
依托单位:
Identification of new mechanistic biomarkers of adverse responses to acetaminophe
-
批准号:7658559
-
项目类别:
-
资助金额:$47.5万
-
财政年份:2009
-
负责人:Laura P James
-
依托单位:
AcetaSTAT Validation and Commercialization
-
批准号:10481793
-
项目类别:
-
资助金额:$106.97万
-
财政年份:2008
-
负责人:Laura P James
-
依托单位:
100 Additional fresh samples for verification of assay to replace the original proposed banked samples that cannot be used due to repeated exposure to freezing and thawing.
-
批准号:10837949
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2008
-
负责人:Laura P James
-
依托单位:
Dipstick Assay for Detection of Acetaminophen Protein Adducts
-
批准号:7591060
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2008
-
负责人:Laura P James
-
依托单位:
AcetaSTAT Validation and Commercialization
-
批准号:10598625
-
项目类别:
-
资助金额:$106.83万
-
财政年份:2008
-
负责人:Laura P James
-
依托单位:
Dipstick Assay for Detection of Acetaminophen Protein Adducts
-
批准号:7480828
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2008
-
负责人:Laura P James
-
依托单位:
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity
-
批准号:8499293
-
项目类别:
-
资助金额:$56.86万
-
财政年份:2008
-
负责人:Laura P James
-
依托单位:
海外基金